Gay NJ - Search Results

1

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Brisson M, et al. Among authors: gay nj. Vaccine. 2002 Jun 7;20(19-20):2500-7. doi: 10.1016/s0264-410x(02)00180-9. Vaccine. 2002. PMID: 12057605

2

Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom.

Choi YH, Jit M, Gay N, Cox A, Garnett GP, Edmunds WJ. Choi YH, et al. Vaccine. 2010 May 28;28(24):4091-102. doi: 10.1016/j.vaccine.2009.09.125. Epub 2009 Nov 10. Vaccine. 2010. PMID: 19909831

3

Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.

van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. van Hoek AJ, et al. Vaccine. 2011 Mar 16;29(13):2411-20. doi: 10.1016/j.vaccine.2011.01.037. Epub 2011 Jan 28. Vaccine. 2011. PMID: 21277405

4

The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.

van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ. van Hoek AJ, et al. Vaccine. 2012 Feb 1;30(6):1225-34. doi: 10.1016/j.vaccine.2011.11.026. Epub 2011 Nov 23. Vaccine. 2012. PMID: 22119592

5

Estimating the impact of childhood influenza vaccination programmes in England and Wales.

Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ. Vynnycky E, et al. Vaccine. 2008 Sep 26;26(41):5321-30. doi: 10.1016/j.vaccine.2008.06.101. Epub 2008 Jul 21. Vaccine. 2008. PMID: 18647634

6

The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales.

Edmunds WJ, Brisson M, Melegaro A, Gay NJ. Edmunds WJ, et al. Among authors: gay nj. Vaccine. 2002 Jan 31;20(9-10):1316-30. doi: 10.1016/s0264-410x(01)00473-x. Vaccine. 2002. PMID: 11818150

7

The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.

Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, Tischer A, Andrews N, Berbers G, Gabutti G, Gay N, Jones L, Jokinen S, Kafatos G, de Aragón MV, Schneider F, Smetana Z, Vargova B, Vranckx R, Miller E. Nardone A, et al. Vaccine. 2007 Nov 7;25(45):7866-72. doi: 10.1016/j.vaccine.2007.07.036. Epub 2007 Aug 8. Vaccine. 2007. PMID: 17919788

8

Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.

van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ. van Hoek AJ, et al. Vaccine. 2009 Feb 25;27(9):1454-67. doi: 10.1016/j.vaccine.2008.12.024. Epub 2009 Jan 9. Vaccine. 2009. PMID: 19135492

9

Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes.

Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Brisson M, et al. Among authors: gay nj. Vaccine. 2000 Jun 15;18(25):2775-8. doi: 10.1016/s0264-410x(00)00100-6. Vaccine. 2000. PMID: 10812218 Clinical Trial.

10

Modelling the impact of immunization on the epidemiology of varicella zoster virus.

Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Brisson M, et al. Among authors: gay nj. Epidemiol Infect. 2000 Dec;125(3):651-69. doi: 10.1017/s0950268800004714. Epidemiol Infect. 2000. PMID: 11218215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters